- Open Access
The characteristics of dyslipidemia patients with different durations in Beijing: a cross-sectional study
- Yingying Liu†1, 2,
- Puhong Zhang†3,
- Wei Wang1,
- Huan Wang1,
- Ling Zhang1,
- Wei Wu1 and
- Xiuhua Guo1Email author
© Liu et al; licensee BioMed Central Ltd. 2010
- Received: 23 June 2010
- Accepted: 13 October 2010
- Published: 13 October 2010
Prevalence of dyslipidemia is high and increases even in younger people. The key aim of this study was to explore the group characteristics of patients in different durations of dyslipidemia and provide clues for the management of dyslipidemia in Beijing.
Patients with short duration of dyslipidemia were mainly characterized by relatively young age, occupational groups, not eating or irregular eating breakfast, less physical activities, having the habit of smoking, and 53.8% is with abnormal LDL-c, 10.4% is with abnormal HDL-c, and 51.5% is with abnormal TG. 54.6% of patients with longer duration is with abnormal LDL-c, 12.8% of them is with abnormal HDL-c, and 57.1% is with abnormal TG. They paid much more attentions to their health, tried to eat breakfast regularly and do more physical activities, gave up smoking, and had regular breakfast, but increasing physiological disorders such as elevated blood pressure and glucose appeared. Severe sequelaes (stroke, myocardial infarction) were mainly observed in patients with the duration of more than 10 years. And in this group the proportions of patients with LDL-c ≥ 4.15 mmol/L and TG ≥ 4.53 mmol/L are the highest among the three groups.
we should strengthen the tertiary prevention and improve the control rate of dyslipidemia in Beijing. Health promotion programs such as tobacco control and physical exercise should be carried out for younger patients.
- Metabolic Syndrome
- Fasting Plasma Glucose
- High Density Lipoprotein Cholesterol
- Impaired Fasting Glucose
- Multiple Correspondence Analysis
Dyslipidemia, a common lipid abnormality is characterized by elevated lowdensity lipoprotein cholesterol (LDL-c), elevated triglycerides (TGs), or low high density lipoprotein cholesterol (HDL-c) . Prevalence of dyslipidemia is high and becomes to increase even in younger people. In addition to elevated LDL-c, both low HDL-c and elevated TG are increasingly being recognized as independent risk factors for coronary heart disease (CHD)[3, 4]. Dyslipidemia is one of the leading causes of death and cardiovascular morbidity in western countries. Hypertension, dyslipidemia, endothelial dysfunction and oxidative stress are the major pathologies involved in CVDs and impose a great risk. Dyslipidemia is responsible for 54% of population attributable risk for myocardial infarction (MI)[7, 8]. Dyslipidemia is also an important contributor to cardiovascular risk in people with metabolic syndrome. Dyslipidemia is consanguineously related with life style. Better high-density lipoprotein (HDL) can be gotten through changing the lifestyle. And hypercholesterolaemia is the permissive factor that allows other risk factors to operate. If the TC decreased 1%, the incidence of CHD will reduce 2%. And if TC decreased 10%, the mortality of CHD will reduce 13%~14%.
The importance of dyslipidemia management is based on cardiovascular risk factors. Assessment of the patient's risk for coronary heart disease helps determine which treatment should be initiated. The lipid management goal is also based on risk assessment and the management of dyslipidemia doesn't always require drug therapy. Particularly, lifestyle modification is important for the management of low HDL-C and TG. We manage to explore the group characteristics of patients in different durations of dyslipidemia through a cross-sectional investigation which will assess cardiovascular risk factors of the dyslipidemia patients and provide clues for the prevention and therapy of dyslipidemia in Beijing.
A cross-sectional study was performed to research the prevalence level of chronic diseases and risk factors in Beijing in 2005, in which, the target people involved was aged ≥ 18 years old and had been living in Beijing for at least 6 months. In the study, 19216 individuals who represented 19216 families involved in the survey with multi-stage cluster sampling study, and this investigation covered 162 communities of 54 sub districts in all 18 municipal districts. The sub districts were sampled with probability proportional to size cluster sampling method in each district. 16711(87.0%) subjects were valid and used in consequent studies. And 2692 diagnosed dyslipidemia patients with complete duration information from the 16711 valid participants were chosen for the correspondence analysis in this study.
Our survey included a questionnaire, physical measurements, blood pressure measurements and laboratory tests to collect information. Before the investigation all the people involved had signed the informed consents. We used Calender 7600 autoanalyzer to test fasting lipid components for the diagnosis of dyslipidemia in the laboratory of Beijing CDC(the Center for Disease Control and Prevention).
Diagnosis methods and a layered approach
Dyslipidemia was diagnosed as any abnormal status of LDL-C, HDL-C and TG (based on the standard of ATPIII: TG ≥ 1.70 mmol/L, LDL-c ≥ 3.46 mmol/L, HDL-c < 0.91 mmol/L), And basing on the standard of ATPIII, TG was divided into four groups(TG < 1.70 mmol/L, 1.70 ≤ TG < 2.27 mmol/L, 2.27 ≤ TG < 4.52 mmol/L, TG ≥ 4.53 mmol/L); LDL-c was divided into three groups(LDL-c < 3.46 mmol/L, 3.46 ≤ LDL-c < 4.15 mmol/L, LDL-c ≥ 4.15 mmol/L); HDL-c was divided into three groups(HDL-c < 0.91 mmol/L, 0.91 ≤ HDL-c < 1.56 mmol/L, HDL-c ≥ 1.56 mmol/L). The duration of dyslipidemia was calculated according to the date on which one was first diagnosed as dyslipidemia patient. Body mass index (BMI) was calculated as body weight divided by height squared (kg/m2). Lower-weight(L-W), normal-weight(N-W), overweight and obesity were defined as BMI < 18.5, 18.5 ≤ BMI < 25, 25 ≤ BMI < 30 and BMI ≥ 30, respectively.
Current smokers included regular and casual smokers within the last month and were classified as non-smoking, 0-9 cigarettes/day, 10-19 cigarettes/day, 20-29 cigarettes/day and ≥ 30 cigarettes/day. Drinking groups included non-drinking (never drink or drink less than 1 time per month), occasional drinking (drink more than 1 time per month but less than 2 times per week) and frequent drinking (drink more than 2 times per week). Lack of physical activities referred to less than 2 hour physical activities per week including walking, dancing, running, swimming and court game, excluding work purpose physical activities. Low-intake of calcium, low-intake of fruit and vegetable and protein intake were all based on food frequency questionnaire.
According to the measurement of blood pressure(BP), we defined the normal BP, borderline hypertension, low-grade hypertension, middle-grade hypertension and high-grade hypertension as SBP < 130 mmHg and DBP < 85 mmHg, 130 mmHg ≤ SBP < 140 mmHg or 85 mmHg ≤ DBP < 90 mmHg, 140 mmHg ≤ SBP < 160 mmHg or 90 mmHg ≤ DBP < 100 mmHg, 160 mmHg ≤ SBP < 180 mmHg or 100 mmHg ≤ DBP < 110 mmHg, SBP ≥ 180 mmHg or DBP ≥ 110 mmHg. And according to the fasting plasma glucose (FPG), normal FPG, impaired fasting glucose(IFG) and diabetes were defined as FPG < 6.1 mmol/L, 6.1 mmol/L ≤ FPG < 7.0 mmol/L and FPG ≥ 7.0 mmol/L. We diagnosed metabolic syndrome (MS) as the standard of ATPIII. The consideration of myocardial infraction and stroke were according to the diagnosis of local hospitals.
The sample size of each duration group was: "0-4 years": 1816 (67.5%); "5-9 years": 517 (19.2%); " ≥ 10 years":359 (13.3%).
All data were doubly input and checked with Epidata3.1 by a professional data recording company. Abnormal values and missing values were checked (logic check) by quality control group to ensure the data accuracy. SAS software (version 9.1, SAS Institute (Shanghai) Co., Ltd.) was used to perform univariate analysis and multiple correspondence analysis. Prior to multiple correspondence analysis, univariate analysis were made to find significant variables. Nonparametric test was used to explore the correlation between a particular correlated factors and durations of dyslipidemia. We performed Mann-Whitney with the variables classified as two levels, and Kruskal-Wallis for variables classified as multilevel out of orders (such as occupation), and Spearman rank correlation analysis for variables classified as multilevel orders.
Correspondence analysis is used to analyze the differences among every sort of one same variable and the corresponding relationship among every sort of variable. This method is converting an original data matrix X = (x) nm contains n subjects and m variables into another matrix Z = (z) nm, and also making R = Z'Z (covariance matrix analyzing the relationship among variables) and Q = ZZ' (covariance matrix analyzing the relationship among subjects) have the same non-zero eigenvalue by utilizing a sort of data transformation method. The horizontal axis of the correspondence analysis graph is the first dimensionality, and the second dimensionality is the vertical axis. The distance between the two variables can indicate the approximate relationship between the two variables[15, 16].
The awareness and control rates of dyslipidemia are low in Beijing
the lipid level and BMI of dyslipidemia patients with different durations
The LDL-c, HDL-c and TG levels of patients with the 0-4 years duration are 3.53 ± 0.96 mmol/L, 1.25 ± 0.32 mmol/L, 2.17 ± 1.72 mmol/L. The LDL-c, HDL-c and TG levels of patients with the 5-9 years duration are 3.56 ± 0.98 mmol/L, 1.23 ± 0.31 mmol/L, 2.37 ± 1.79 mmol/L. The LDL-c, HDL-c and TG levels of patients with the ≥ 10 years duration are 3.56 ± 0.961.19 mmol/L, 1.26 ± 0.36 mmol/L, 2.38 ± 1.89 mmol/L. 53.8% of patients in 0-4 years duration is with abnormal LDL-c, 10.4% is with abnormal HDL-c, and 51.5% is with abnormal TG, while 47.2% is overweight and 27.3% is obesity; 54.6% of patients in 5-9 years duration is with abnormal LDL-c, 12.8% is with abnormal HDL-c, and 57.1% is with abnormal TG, while 46.8% is overweight and 30.2% is obesity; 56.9% of patients in 10 years or more duration is with abnormal LDL-c, 12.6% is with abnormal HDL-c, and 53.6% is with abnormal TG, while 43.3% is overweight and 33.2% is obesity. The proportion of patients with LDL-c ≥ 4.15 mmol/L is increasing with the increasing duration among the three groups while the proportion of patients with 3.46 mmol/L ≤ LDL-c < 4.15 mmol/L is decreasing. The proportion of obese people is increasing with the increasing duration among the three groups.
Distribution of correlated factors and diseases in patients with different durations of dyslipidemia
Distribution of correlated factors in patients with different durations of dyslipidemia
Distribution of the correlated diseases in patients with different duration of dyslipidemia
Multiple correspondence analysis on the durations of dyslipidemia and correlated factors
As an extension to principal component analysis, correspondence analysis is a kind of descriptive multi-variable analysis method, factor analysis and canonical correlation analysis. Through projection from vector point of high dimensional space to lower dimensional space, multiple correspondence analysis can be used to clearly illustrate correlations among multiple variables in one simple two dimension chart through projection from vector point of high dimensional space to lower dimensional space, therefore, can generate some benefits like that intuition, convenience, strong discriminating ability and saving calculating time, etc[15, 16]. In our study the multiple variables assemble obviously.
The INTERHEART study also showed that nine traditional risk factors (smoking, hypertension, diabetes, obesity, diet, physical activity, alcohol consumption, psychosocial factors, and dyslipidemia) contributed to the high CHD burden in the South Asian population as in other countries. From the review of the report 'the nutrition and health status of Chinese' which was published by medical ministry of People's Republic of China in Oct, 2004, we knew that the prevalence of chronic disease such as hypertension, diabetes and dyslipidemia ascended rapidly and the unhealthy lifestyle was the main risk factor. Many researches had mentioned that direct or indirect smoking was one of the most important risk factors of dyslipidemia[17–19]. And the same Lack of physical activities and the habit of sedentariness were another risk factor of dyslipidemia. And study suggested high prevalence of dyslipidemia in all age groups both in males and females and the prevalences were increasing with age. In our study we also found that patients with shorter duration were closely related with lack of physical activities and having the habit of smoking. But the elder patients began to pay more attention to their health. And they tried to change their unhealthy lifestyle such as eating breakfast regularly, giving up smoking and doing more physical exercises, but metabolic syndrome had taken place in this period and critical hypertension and IFG happened during this period.
Tenkanen L' data showed that patients with dyslipidemia and features associated with the metabolic syndrome(BMI and TG in the highest tertiles). Hypertension, diabetes, and dyslipidemia are all factors individually associated with increased risk for mortality from cardiovascular disease and all-cause mortality. Some type of diet was tested in clinical trials in Italy and shown to lower blood pressure and improve dyslipidemia. Forsythe's study had suggested that a healthier diet favorably and strongly affects dyslipidemia and hypertension, even in obese patients who do not lose weight. It has been indicated the combination of aerobic and resistance exercise may provide greater benefit in people with dyslipidemia and other components of the metabolic syndrome because of the combined effects of reduced adiposity, increased muscle mass, and improved myocyte function, including increased oxidative capacity. According to the characteristics of patients with different duration of dyslipidemia in Beijing, We found the clues for the strategies about the prevention of dyslipidemia. At the earlier of dyslipidemia, patients were relatively young, lack of healthy sense, with the unhealthy life-style. With the development of dyslipidemia patients gradually suffered from other chronic diseases and they began to pay more attention to their health and change their unhealthy life-style. But with the effects of multiple causes myocardial infarction and stroke were inevitable. According to those characters, the strategies about the prevention of should be developed with changing young people's risk behavior. Because of the clustering of dyslipidemia, diabetes, hypertension and obesity, a comprehensive strategy should be made to improve the prevention of cardiovascular disease.
Because many different risk factors affect dyslipidemia patients with different duration, potentially complementary mechanisms of action, combination control may offer additional beneficial effects to patients with different duration of dyslipidemia. This study demonstrates that different duration of dyslipidemia with different risk factors which can effectively improve multiple intervention measures to a greater extent in patients with dyslipidemia, without significantly increasing the risk for adverse events commonly associated with unified intervention model. These findings in our paper have important public health implications for the prevention and treatments of dyslipidemia.
According to our research, we should strengthen the tertiary prevention and improve the control rate of dyslipidemia in Beijing. Community physicians should take effective measures to control blood lipids for patients with dyslipidemia. We should strengthen the prevention and treatment of dyslipidemia for younger people, Particularly for the working groups and community retired residents. Health promotion programs such as tobacco control and physical exercise should be carried out for younger patients. Community hospitals should establish files with chronic diseases patients. The blood lipids, blood glucose, blood pressure should strictly controlled for the dyslipidemia patients with the duration of more than five years and then we can prevent the serious complications such as myocardial infarction and stroke.
This project was funded by Beijing Health Bureau; The program of Natural Science Fund of China (Serial Number: 30972550); the program of Natural Science Fund of Beijing (Serial Number: 7092010); Program of Funds: The program of Natural Science Fund of China (Serial Number: 30972550); the program of Natural Science Fund of Beijing (Serial Number: 7092010); the program of Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality(Serial Number: PHR201007112) and the program of Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality(Serial Number: PHR201007112). The authors thank all the 18 CDC Chronic Disease Departments for their contribution to local investigate and implement.
- Mohiuddin SM, Pepine CJ, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC: Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study. American Heart Journal. 2009, 157: 195-203. 10.1016/j.ahj.2008.08.027View ArticlePubMedGoogle Scholar
- Caprnda M, Dukat A, Lietava J, Fodor JG: High prevalences of mixed dyslipidemia in healthy Slovak people. Journal of Clinical Lipidology. 2008, 2: 541-Google Scholar
- Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W: Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The atherosclerosis risk in communities (ARIC) Study. Circulation. 2001, 104: 1108-13. 10.1161/hc3501.095214View ArticlePubMedGoogle Scholar
- Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V: Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation. 2007, 115: 450-8. 10.1161/CIRCULATIONAHA.106.637793View ArticlePubMedGoogle Scholar
- Abello F, Baracco V, Guardamagna O: Diagnostic and clinical aspects of children affected by primary mixed dyslipidemia. Nutrition, Metabolism & Cardiovascular Diseases. 2008, 18: 35View ArticleGoogle Scholar
- Aziz N, Mehmood MH, Mandukhal SR, Bashir S, Raoof S, Gilani AH: Antihypertensive, antioxidant, antidyslipidemic and endothelial modulating activities of a polyherbal formulation (POL-10). Vascular Pharmacology. 2009, 50: 57-64. 10.1016/j.vph.2008.09.003View ArticlePubMedGoogle Scholar
- Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Casecontrol study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9View ArticlePubMedGoogle Scholar
- Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P: The residual risk reduction Initiative: A call to action to reduce residual vascular risk in patients with mixed dyslipidemia. The American Journal of Cardiology. 2008, 102: 2-34. 10.1016/j.amjcard.2008.10.002.View ArticleGoogle Scholar
- Paul MS, LaFontaine T, Thomas TR: Know the risks: Lifestyle management of mixed dyslipidemia. ACSM's Health & Fitness Journal. 2006, 10: 18-25.View ArticleGoogle Scholar
- Whittemore R, Melkus G, Wagner J, Dziura J, Northrup V, Grey M: Translating the diabetes prevention program to primary care: A pilot study. Nurs Res. 2009, 58: 2-12. 10.1097/NNR.0b013e31818fcef3PubMed CentralView ArticlePubMedGoogle Scholar
- Libby P: Inflammation in atherosclerosis. Nature. 2002, 420: 868-74. 10.1038/nature01323View ArticlePubMedGoogle Scholar
- Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD: Cholesterol reduction yields clinical benefit: a new look at old data. Circulation. 1995, 91: 2274-82.View ArticlePubMedGoogle Scholar
- Syed MA, Mark EC, John FD: Management of Dyslipidemia in Adults. American family physician. 1998, 5: 2207-Google Scholar
- Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Goals of dyslipidemia management. Journal of Atheroscler Thromb. 2007, 14: 2009-12.Google Scholar
- Perriere G, Thioulouse J: Use and misuse of correspondence analysis in codon usage studies. Nucleic Acids Research. 2002, 30: 4548-55. 10.1093/nar/gkf565PubMed CentralView ArticlePubMedGoogle Scholar
- Busold CH, Winter S, Hauser N, Bauer A, Dippon J, Hoheisel JD, Fellenberg K: Integration of go annotations in correspondence analysis: Facilitating the interpretation of micro-array data. Bioinformatics. 2005, 21: 2424-29. 10.1093/bioinformatics/bti367View ArticlePubMedGoogle Scholar
- Neufeld EJ, Mietus-Snyder M, Beiser AS, Baker AL, Newburger JW: Passive cigarette smoking and reduced HDL cholesterol levels in children with high 2 risk lipid profiles. Circulation. 1997, 96: 1403-7.View ArticlePubMedGoogle Scholar
- Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ: Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999, 319: 1523-8.PubMed CentralView ArticlePubMedGoogle Scholar
- Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH: A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996, 276: 882-8. 10.1001/jama.276.11.882View ArticlePubMedGoogle Scholar
- Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS: Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008, 43: 65-77. 10.1007/s11745-007-3132-7View ArticlePubMedGoogle Scholar
- Caprnda M, Dukat A, Lietava J, Fodor JG: High prevalences of mixed dyslipidemia in healthy Slovak people. Journal of Clinical Lipidology. 2008, 2: 541-Google Scholar
- Tenkanen L, Mänttäri M, Kovanen PT, Virkkunen H, Manninen V: Gemfibrozil in the treatment of mixed dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study. Arch Intern Med. 2006, 166: 743-8. 10.1001/archinte.166.7.743View ArticlePubMedGoogle Scholar
- Avins AL, Neuhaus JM: Do triglycerides provide meaningful information about heart disease risk?. Arch Int Med. 2000, 160: 1937-44. 10.1001/archinte.160.13.1937.View ArticleGoogle Scholar
- Esposito K, Marfella R, Ciotola M, Palo CD, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004, 292: 1440-6. 10.1001/jama.292.12.1440View ArticlePubMedGoogle Scholar
- Stewart KJ, Bacher AC, Turner K, Lim JG, Hees PS, Shapiro EP, Tayback M, Ouyang P: Exercise and risk factors associated with metabolic syndrome in older adults. Am J Prev Med. 2005, 28: 9-18. 10.1016/j.amepre.2004.09.006View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.